UroGen Pharma URGN Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's increase (decrease) in prepaid expense and other assets?
- UroGen Pharma (URGN) reported increase (decrease) in prepaid expense and other assets of $4.86M in Q1 2026.
- How has UroGen Pharma's increase (decrease) in prepaid expense and other assets changed year-over-year?
- UroGen Pharma's increase (decrease) in prepaid expense and other assets increased by 17.4% year-over-year, from $4.14M to $4.86M.
- What is the long-term trend for UroGen Pharma's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2024), UroGen Pharma's increase (decrease) in prepaid expense and other assets has grown at a -37.1% compound annual growth rate (CAGR), from $3.63M to -$1.44M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.